CPA4 and cancer: In summary, the challenges include the following: (1) the exact substrates and molecular pathways regulated by CPA4 in cancer are not fully understood; (2) selective targeting of CPA4 without affecting other related carboxypeptidases remains a challenge; and (3) validation of potential role of CPA4 in cancer with multiple studies to ensure rigor.